78 related articles for article (PubMed ID: 20108563)
1. Transformation of MALT lymphoma to pure plasma cell histology: possible association with anti-CD20 antibody treatment.
Klein N; Elis A; Radnay J; Zemer R; Klein A; Lishner M
Isr Med Assoc J; 2009 Nov; 11(11):703-4. PubMed ID: 20108563
[No Abstract] [Full Text] [Related]
2. [Pulmonary MALT lymphoma with macroglobulinemia].
Takasaki H; Takabayashi M; Yamaji S; Koharazawa H; Fujimaki K; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Feb; 46(2):144-6. PubMed ID: 16447709
[TBL] [Abstract][Full Text] [Related]
3. Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab.
Woehrer S; Streubel B; Chott A; Hoffmann M; Raderer M
Leuk Lymphoma; 2005 Nov; 46(11):1645-9. PubMed ID: 16236618
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva.
Nückel H; Meller D; Steuhl KP; Dührsen U
Eur J Haematol; 2004 Oct; 73(4):258-62. PubMed ID: 15347312
[TBL] [Abstract][Full Text] [Related]
5. Rituximab as first line treatment for MALT lymphoma of extraocular muscles.
Benetatos L; Alymara V; Asproudis I; Bourantas KL
Ann Hematol; 2006 Sep; 85(9):625-6. PubMed ID: 16691396
[No Abstract] [Full Text] [Related]
6. [Mucosa-associated lymphoid tissue lymphoma of the lung].
Muro M; Yoshioka T; Idani H; Ishikawa T; Ishii T; Asami S; Kubo S; Kurose Y; Hirata M; Yamashita T; Kin H
Kyobu Geka; 2008 Nov; 61(12):1026-9. PubMed ID: 19048901
[TBL] [Abstract][Full Text] [Related]
7. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
Arcaini L; Burcheri S; Rossi A; Passamonti F; Paulli M; Boveri E; Brusamolino E; Orlandi E; Molteni A; Pulsoni A; Cox MC; Orsucci L; Fabbri A; Frezzato M; Voso MT; Zaja F; Montanari F; Pascutto C; Morra E; Cortelazzo S; Lazzarino M
Oncologist; 2006 Mar; 11(3):285-91. PubMed ID: 16549813
[TBL] [Abstract][Full Text] [Related]
8. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.
Seker M; Bilici A; Ustaalioglu BO; Salman T; Sonmez B; Canpolat NA; Salepci T; Gumus M; Yaylaci M
Leuk Res; 2009 Sep; 33(9):e154-6. PubMed ID: 19386361
[No Abstract] [Full Text] [Related]
9. Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome.
Harner KC; Jackson LW; Drabick JJ
Rheumatology (Oxford); 2004 Oct; 43(10):1309-10. PubMed ID: 15448217
[No Abstract] [Full Text] [Related]
10. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature.
Alvaro-Naranjo T; Jaén-Martínez J; Gumá-Padró J; Bosch-Príncep R; Salvadó-Usach MT
Ann Hematol; 2003 Sep; 82(9):585-8. PubMed ID: 12898184
[TBL] [Abstract][Full Text] [Related]
11. Successful rituximab monotherapy for API2-MALT1 fusion positive primary mucosa-associated lymphoid tissue lymphoma of the transverse colon in a patient with liver cirrhosis.
Yamada M; Kawahara H; Shiroeda H; Tsuchishima M; Masaki Y; Sato K; Takase S
Scand J Gastroenterol; 2008; 43(6):761-4. PubMed ID: 18569996
[No Abstract] [Full Text] [Related]
12. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.
Martinelli G; Laszlo D; Ferreri AJ; Pruneri G; Ponzoni M; Conconi A; Crosta C; Pedrinis E; Bertoni F; Calabrese L; Zucca E
J Clin Oncol; 2005 Mar; 23(9):1979-83. PubMed ID: 15668468
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.
Niscola P; Palumbo R; Scaramucci L; Tendas A; Cupelli L; Giovannini M; Piccioni D; Dentamaro T; Perrotti AP; de Fabritiis P
Cancer Chemother Pharmacol; 2009 Mar; 63(4):759-60. PubMed ID: 18500519
[No Abstract] [Full Text] [Related]
14. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
Gellrich S; Muche JM; Wilks A; Jasch KC; Voit C; Fischer T; Audring H; Sterry W
Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
[TBL] [Abstract][Full Text] [Related]
15. Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab.
Salar A; Bellosillo B; Serrano S; Besses C
J Clin Oncol; 2005 Oct; 23(29):7361-2; author reply 7362-3. PubMed ID: 16210674
[No Abstract] [Full Text] [Related]
16. Small-cell lung cancer arising after chemotherapy for a patient with lymphoma of pulmonary mucosa-associated lymphoid tissue-a case report.
Nakao M; Oguri T; Maeno K; Kusumoto S; Ota C; Takakuwa O; Uemura T; Ozasa H; Iwashima Y; Miyazaki M; Kutsuna T; Nakamura A; Inagaki H; Sato S; Ueda R
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1711-4. PubMed ID: 19838033
[TBL] [Abstract][Full Text] [Related]
17. Primary marginal zone B-cell lymphoma of gastrointestinal tract presenting as multiple lymphomatoid polyposis.
Kyung Shin B; Lee H; Choi J; Kim A; Kim H; Park J; Kim I
Int J Colorectal Dis; 2007 Aug; 22(8):991-2. PubMed ID: 16586077
[No Abstract] [Full Text] [Related]
18. Edema of the eyelids and sclera after rituximab infusion for orbital MALT lymphoma.
Oribe N; Tanimoto TE; Shimoda K; Hikiji W; Mitsugi K; Takase K; Henzan H; Numata A; Miyamoto T; Fukuda T; Nagafuji K; Harada M
Haematologica; 2004 Jun; 89(6 Suppl):EIM14. PubMed ID: 15194556
[No Abstract] [Full Text] [Related]
19. Multiparametric flow cytometry in the diagnosis and characterization of low-grade pulmonary mucosa-associated lymphoid tissue lymphomas.
Zaer FS; Braylan RC; Zander DS; Iturraspe JA; Almasri NM
Mod Pathol; 1998 Jun; 11(6):525-32. PubMed ID: 9647589
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S
Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
